David Peoples
David is Chief Business and Financial Officer of Ultima Genomics and leads the firms business development and financial functions. Prior to Ultima, David was an investment banker for 20 years and was a Managing Director at J.P. Morgan, where he was responsible for coverage of the life sciences tools and diagnostics sectors for the healthcare investment banking team. While at J.P. Morgan, David raised billions of dollars of capital for industry and led many of the recent and successful initial public offerings that helped build the emerging life sciences tools & diagnostics ecosystem. David received a BS in Economics from Davidson College.
Ultima Genomics
Reading and Writing: How Far, How Fast, & When?
-
This session will examine the frontiers of genomic sequencing and synthesis, providing a critical assessment of the present capabilities and charting likely trajectories for future progress. Participants will highlight the latest advances in instrumentation, informatics, and automation that are pushing beyond conventional limits, while also considering emerging technologies poised to reshape the landscape of DNA reading and writing. By focusing on accuracy, throughput, and scalability, this discussion will illuminate the fundamental shifts now taking place and the new horizons they open for biological research and innovation.
Conference Pass
2,495
USD
Keynotes & Firesides
Workshops & Breakouts
1:1 Partnering App
Meals & Receptions
Session Recordings
Until Friday April 18th
Full Rate:
$3,495
